Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID 19) Virus-Neutralizing Antibodies in Human Clinical Samples
M. R. Holbrook, R. S. Bennett, E. N. Postnikova, J. Liang, R. Gross, D. Gerhardt, S. Georgia-Clark, Y. Cai, S. Yu, L. Marron, G. Kocher, S. Mazur, S. Dixit, V. V. Lukin
The paper describes a modified fluorescence reduction neutralization assay for quantitatively assessing SARS-CoV-2 neutralizing antibodies in clinical samples, demonstrating its efficiency and accuracy.
bioRxiv · Mar 5, 2021Immunology